HOMEOPATHY IN HYPOTHYROIDISM: A CRITICAL REVIEW OF EVIDENCE, BIAS, AND CLINICAL RELEVANCE
International Journal of Advanced Research · 31.05.2026 · 14 (05) · 1419-1438
DOI: 10.21474/ijar01/23546 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Advanced Research, online erschienen am 31.05.2026. Verfasst von Pankaj N.Lathiya und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Hypothyroidism is a common endocrine disorder characterized by insufficient thyroid hormone availability, usually reflected in elevated thyroid-stimulating hormone (TSH) in primary disease and reduced free thyroxine (FT4) in overt disease. Although levothyroxine remains the standard replacement therapy, some patients seek homeopathy because of residual symptoms, concerns about lifelong medication, preference for individualized consultation, and cultural acceptance of complementary medicine.
Objective
This review critically evaluates recent evidence from 2020 to 2025 on homeopathy in hypothyroidism and related thyroid disorders, with emphasis on clinical outcomes, methodological bias, biological plausibility, placebo and contextual effects, and practical clinical relevance.
Zitieren
APA
N.Lathiya, P., Kapare, M., & Sindhi, A. (2026). HOMEOPATHY IN HYPOTHYROIDISM: A CRITICAL REVIEW OF EVIDENCE, BIAS, AND CLINICAL RELEVANCE. International Journal of Advanced Research, 14(05), 1419-1438. https://doi.org/10.21474/ijar01/23546
Vancouver
N.Lathiya P, Kapare M, Sindhi A. HOMEOPATHY IN HYPOTHYROIDISM: A CRITICAL REVIEW OF EVIDENCE, BIAS, AND CLINICAL RELEVANCE. International Journal of Advanced Research. 2026;14(05):1419-1438. doi:10.21474/ijar01/23546
BibTeX
@article{NLathiya2026,
author = {N.Lathiya, Pankaj and Kapare, Mandar and Sindhi, Anjali},
title = {HOMEOPATHY IN HYPOTHYROIDISM: A CRITICAL REVIEW OF EVIDENCE, BIAS, AND CLINICAL RELEVANCE},
journal = {International Journal of Advanced Research},
year = {2026},
volume = {14},
number = {05},
pages = {1419--1438},
doi = {10.21474/ijar01/23546}
}
EUVIMED